참고문헌
- Thandra KC, Barsouk A, Saginala K, Aluru JS, Barsouk A. Epidemiology of lung cancer. Contemp Oncol (Pozn) 2021;25:45-52. https://doi.org/10.5114/wo.2021.103829
- Venuta F, Diso D, Onorati I, Anile M, Mantovani S, Rendina EA. Lung cancer in elderly patients. J Thorac Dis 2016;8(Suppl 11): S908-14. https://doi.org/10.21037/jtd.2016.05.20
- Wang JC, Bennett M. Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ Res 2012;111:245-59. https://doi.org/10.1161/circresaha.111.261388
- Jonsson F, Yin L, Lundholm C, Smedby KE, Czene K, Pawitan Y. Low-dose aspirin use and cancer characteristics: a population-based cohort study. Br J Cancer 2013;109:1921-5. https://doi.org/10.1038/bjc.2013.411
- Eikelboom JW, Hirsh J, Spencer FA, Baglin TP, Weitz JI. Antiplatelet drugs: antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012;141(2 Suppl):e89S-e119S. https://doi.org/10.1378/chest.11-2293
- Kim DH, Daskalakis C, Silvestry SC, et al. Aspirin and clopidogrel use in the early postoperative period following on-pump and off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg 2009;138:1377-84. https://doi.org/10.1016/j.jtcvs.2009.07.027
- Ferraris VA, Saha SP, Oestreich JH, et al. 2012 Update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. Ann Thorac Surg 2012;94:1761-81. https://doi.org/10.1016/j.athoracsur.2012.07.086
- Chassot PG, Delabays A, Spahn DR. Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth 2007;99:316-28. https://doi.org/10.1093/bja/aem209
- Cassiano F, Menna C, Andreetti C, Ibrahim M. Major thoracic surgery in patients under antiplatelet therapy. Transl Cancer Res 2016;5(Suppl 7):S1473-5. https://doi.org/10.21037/tcr.2016.12.64
- Gerstein NS, Albrechtsen CL, Mercado N, Cigarroa JE, Schulman PM. A comprehensive update on aspirin management during noncardiac surgery. Anesth Analg 2020;131:1111-23. https://doi.org/10.1213/ane.0000000000005064
- Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention, 2011 ACCF/AHA guideline for coronary artery bypass graft surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. Circulation 2016;134:e123-55. https://doi.org/10.1161/cir.0000000000000404
- Devereaux PJ, Mrkobrada M, Sessler DI, et al. Aspirin in patients undergoing noncardiac surgery. N Engl J Med 2014;370:1494-503. https://doi.org/10.1056/nejmoa1401105
- Lewis SR, Pritchard MW, Schofield-Robinson OJ, Alderson P, Smith AF. Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non-cardiac surgery. Cochrane Database Syst Rev 2018;7:CD012584. https://doi.org/10.1002/14651858.cd012584.pub2
- Burger W, Chemnitius JM, Kneissl GD, Rucker G. Low-dose aspirin for secondary cardiovascular prevention: cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation. Review and meta-analysis. J Intern Med 2005;257:399-414. https://doi.org/10.1111/j.1365-2796.2005.01477.x
- Yu WS, Lee CY. Safety of perioperative low dose aspirin therapy in major lung resection. J Thorac Dis 2019;11(Suppl 15):S1897-9. https://doi.org/10.21037/jtd.2019.08.43
- Yoon DW, Shin DW, Cho JH, et al. Impact of previous percutaneous coronary intervention on cardiovascular outcomes and mortality after lung cancer surgery: a nationwide study in Korea. Thorac Cancer 2020;11:2517-28. https://doi.org/10.1111/1759-7714.13563
- Egholm G, Thim T, Olesen KK, et al. Dual anti-platelet therapy after coronary drug-eluting stent implantation and surgery-associated major adverse events. Thromb Haemost 2016;116:172-80. https://doi.org/10.1160/th15-12-0954
- Navi BB, Reiner AS, Kamel H, et al. Risk of arterial thromboembolism in patients with cancer. J Am Coll Cardiol 2017;70:926-38. https://doi.org/10.1016/j.jacc.2017.06.047
- Navi BB, Reiner AS, Kamel H, et al. Association between incident cancer and subsequent stroke. Ann Neurol 2015;77:291-300. https://doi.org/10.1002/ana.24325
- Dobrev D, Aguilar M, Heijman J, Guichard JB, Nattel S. Postoperative atrial fibrillation: mechanisms, manifestations and management. Nat Rev Cardiol 2019;16:417-36. https://doi.org/10.1038/s41569-019-0166-5
- Semeraro GC, Meroni CA, Cipolla CM, Cardinale DM. Atrial fibrillation after lung cancer surgery: prediction, prevention and anticoagulation management. Cancers (Basel) 2021;13:4012. https://doi.org/10.3390/cancers13164012
- Yamashita K, Hu N, Ranjan R, Selzman CH, Dosdall DJ. Clinical risk factors for postoperative atrial fibrillation among patients after cardiac surgery. Thorac Cardiovasc Surg 2019;67:107-16. https://doi.org/10.1055/s-0038-1667065
- Freeman LC, Narvaez DF, McCoy A, et al. Depolarization and decreased surface expression of K+ channels contribute to NSAID-inhibition of intestinal restitution. Biochem Pharmacol 2007;74:74-85. https://doi.org/10.1016/j.bcp.2007.03.030
- Lardinois D, Vogt P, Yang L, Hegyi I, Baslam M, Weder W. Non-steroidal anti-inflammatory drugs decrease the quality of pleurodesis after mechanical pleural abrasion. Eur J Cardiothorac Surg 2004;25:865-71. https://doi.org/10.1016/j.ejcts.2004.01.028